Search
SOLACI Congress
HomePeripheral vascular diseaseRenal

Renal

View Category

Peripheral vascular disease

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although...
Dr. Juan Manuel Pérez -
Learn More
Left Atrial Apendix Closure

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population...
Dr. Andrés Rodríguez -
Learn More
Peripheral vascular disease

Evolution of Renal Denervation at 24 Months

Arterial hypertension is a modifiable risk factor for cardiovascular events. In many cases, however, patients struggle to...
Dr. Carlos Fava -
Learn More
Peripheral vascular disease

Renal Denervation and SPYRAL HTN-ON MED Two-Year Outcomes

High blood pressure (BP) continues to be one of the leading preventable causes of cardiovascular events worldwide....
Dr. Omar Tupayachi -
Learn More
Peripheral vascular disease

Renal Denervation, 24-Month Evolution

Hypertension is a very common condition, and generally manageable. However, as we know, it is associated to...
Dr. Carlos Fava -
Learn More
Peripheral vascular disease

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac...
Dr. Omar Tupayachi -
Learn More
Peripheral vascular disease

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

Hypertension treatment has evolved considerably over time. However, managing adverse events driven by medication is still challenging,...
solaci -
Learn More
Peripheral vascular disease

Renal Denervation is Safe and Reduces Blood Pressure and Medication

We are well aware of the multifactorial nature of hypertension, as well as the fact that it...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy